July 1, 2025 Where to Rent Stable Turkish Datacenter Proxies?
June 24, 2025 PayPal’s News Analysis—A Short and Medium-Term Price Forecast
June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
Oramed Pharmaceuticals (ORMP) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: July 7, 2025 (23:24)
Sector: HealthcareThe share price of Oramed Pharmaceuticals Inc. (ORMP) now
Are you interested in Oramed Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Oramed Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Oramed Pharmaceuticals share be worth in 2025 - 2027?
When should I take profit in Oramed Pharmaceuticals stock? When should I record a loss on Oramed Pharmaceuticals stock? What are analysts' forecasts for Oramed Pharmaceuticals stock? What is the future of Oramed Pharmaceuticals stock? We forecast Oramed Pharmaceuticals stock performance using neural networks based on historical data on Oramed Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Oramed Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Oramed Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Oramed Pharmaceuticals stock
The chart below shows the historical price of Oramed Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Oramed Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Oramed Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul 09 | 2.17 | 2.14 | 2.20 | 2.98 |
| Jul 10 | 2.18 | 2.16 | 2.20 | 1.78 |
| Jul 11 | 2.18 | 2.16 | 2.20 | 1.90 |
| Jul 12 | 2.18 | 2.16 | 2.20 | 1.66 |
| Jul 13 | 2.21 | 2.20 | 2.25 | 2.23 |
| Jul 14 | 2.20 | 2.18 | 2.21 | 1.82 |
| Jul 15 | 2.20 | 2.19 | 2.22 | 1.59 |
| Jul 16 | 2.22 | 2.19 | 2.24 | 2.25 |
| Jul 17 | 2.22 | 2.19 | 2.23 | 2.03 |
| Jul 18 | 2.21 | 2.19 | 2.23 | 2.16 |
| Jul 19 | 2.17 | 2.15 | 2.19 | 1.76 |
| Jul 20 | 2.17 | 2.15 | 2.18 | 1.41 |
| Jul 21 | 2.16 | 2.15 | 2.19 | 1.97 |
| Jul 22 | 2.19 | 2.16 | 2.20 | 1.68 |
| Jul 23 | 2.18 | 2.17 | 2.20 | 1.67 |
| Jul 24 | 2.21 | 2.18 | 2.22 | 1.76 |
| Jul 25 | 2.20 | 2.18 | 2.21 | 1.43 |
| Jul 26 | 2.20 | 2.18 | 2.23 | 2.31 |
| Jul 27 | 2.22 | 2.20 | 2.23 | 1.37 |
| Jul 28 | 2.23 | 2.20 | 2.27 | 3.07 |
| Jul 29 | 2.24 | 2.23 | 2.27 | 1.89 |
| Jul 30 | 2.24 | 2.22 | 2.27 | 2.59 |
| Jul 31 | 2.23 | 2.21 | 2.26 | 2.20 |
| Aug 01 | 2.22 | 2.20 | 2.23 | 1.41 |
| Aug 02 | 2.26 | 2.24 | 2.29 | 2.22 |
| Aug 03 | 2.28 | 2.25 | 2.31 | 2.86 |
| Aug 04 | 2.29 | 2.26 | 2.32 | 2.56 |
| Aug 05 | 2.28 | 2.25 | 2.31 | 2.42 |
| Aug 06 | 2.26 | 2.25 | 2.29 | 1.99 |
| Aug 07 | 2.24 | 2.22 | 2.28 | 2.88 |
Oramed Pharmaceuticals Daily Price Targets
Oramed Pharmaceuticals Stock Forecast 07-09-2025.
Forecast target price for 07-09-2025: $2.17.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 2.898%.
Pessimistic target level: 2.14
Optimistic target level: 2.20
Oramed Pharmaceuticals Stock Forecast 07-10-2025.
Forecast target price for 07-10-2025: $2.18.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 1.745%.
Pessimistic target level: 2.16
Optimistic target level: 2.20
Oramed Pharmaceuticals Stock Forecast 07-11-2025.
Forecast target price for 07-11-2025: $2.18.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 1.864%.
Pessimistic target level: 2.16
Optimistic target level: 2.20
Oramed Pharmaceuticals Stock Forecast 07-12-2025.
Forecast target price for 07-12-2025: $2.18.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 1.628%.
Pessimistic target level: 2.16
Optimistic target level: 2.20
Oramed Pharmaceuticals Stock Forecast 07-13-2025.
Forecast target price for 07-13-2025: $2.21.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 2.185%.
Pessimistic target level: 2.20
Optimistic target level: 2.25
Oramed Pharmaceuticals Stock Forecast 07-14-2025.
Forecast target price for 07-14-2025: $2.20.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 1.787%.
Pessimistic target level: 2.18
Optimistic target level: 2.21
ORMP (ORMP) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 2.18 | 2.00 | 2.26 | 11.51 |
| Aug. | 2.40 | 2.28 | 2.51 | 9.11 |
| Sep. | 2.41 | 2.28 | 2.65 | 14.12 |
| Oct. | 2.31 | 2.21 | 2.41 | 8.42 |
| Nov. | 2.40 | 2.25 | 2.52 | 10.66 |
| Dec. | 2.54 | 2.43 | 2.74 | 11.05 |
Oramed Pharmaceuticals forecast for this year
Oramed Pharmaceuticals Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $2.18275. Pessimistic: $2.00. Optimistic: $2.26
Oramed Pharmaceuticals Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $2.39972. Pessimistic: $2.28. Optimistic: $2.51
Oramed Pharmaceuticals Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $2.4098. Pessimistic: $2.28. Optimistic: $2.65
Oramed Pharmaceuticals Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $2.30521. Pessimistic: $2.21. Optimistic: $2.41
Oramed Pharmaceuticals Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $2.39558. Pessimistic: $2.25. Optimistic: $2.52
Oramed Pharmaceuticals Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $2.53979. Pessimistic: $2.43. Optimistic: $2.74
Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.68 | 2.58 | 2.77 | 6.77 |
| Feb | 2.86 | 2.66 | 2.96 | 10.15 |
| Mar | 2.89 | 2.62 | 3.12 | 16.04 |
| Apr | 2.58 | 2.41 | 2.78 | 13.29 |
| May | 2.58 | 2.35 | 2.84 | 17.38 |
| Jun | 2.72 | 2.48 | 2.82 | 11.89 |
| Jul | 2.74 | 2.46 | 3.04 | 19.14 |
| Aug | 2.57 | 2.34 | 2.69 | 13.00 |
| Sep | 2.83 | 2.66 | 2.91 | 8.43 |
| Oct | 2.81 | 2.53 | 3.11 | 18.85 |
| Nov | 3.09 | 2.80 | 3.24 | 13.36 |
| Dec | 3.51 | 3.24 | 3.77 | 14.09 |
Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.74 | 3.40 | 4.13 | 17.72 |
| Feb | 3.57 | 3.42 | 3.84 | 11.06 |
| Mar | 3.51 | 3.15 | 3.88 | 18.78 |
| Apr | 3.58 | 3.44 | 3.86 | 10.78 |
| May | 3.83 | 3.50 | 4.26 | 17.88 |
| Jun | 3.67 | 3.32 | 4.05 | 17.89 |
| Jul | 4.18 | 4.04 | 4.43 | 8.85 |
| Aug | 4.43 | 4.14 | 4.71 | 12.00 |
| Sep | 4.95 | 4.77 | 5.50 | 13.25 |
| Oct | 5.16 | 4.74 | 5.60 | 15.24 |
| Nov | 5.21 | 4.67 | 5.36 | 12.92 |
| Dec | 5.01 | 4.78 | 5.24 | 8.83 |
Oramed Pharmaceuticals information and performance
HI-TECH PARK 2/4 GIVAT-RAM, PO BOX 39098, JERUSALEM, IL
Market capitalization of the Oramed Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ORMP shares in the company outstanding by the market price of one share.
EBITDA of Oramed Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Oramed Pharmaceuticals Stock)
Should I Buy Oramed Pharmaceuticals Shares in 2025 year?
Does Oramed Pharmaceuticals pay dividends?
Which economic sector do Oramed Pharmaceuticals's shares belong to?
Which other securities belong to the same sector as Oramed Pharmaceuticals's shares?
